Dyadic International (DYAI) Interest Coverage Ratio (2024 - 2026)
Dyadic International's (DYAI) quarterly Interest Coverage Ratio came in at 29.57 in Q1 2026, down 31.79% year-over-year from 43.35 in Q1 2025, and down 29.81% quarter-over-quarter from 22.78 in Q4 2025.
Analysis
Dyadic International (DYAI) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Dyadic International has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 29.57 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 31.79% year-over-year to 29.57; the TTM figure through Mar 2026 stood at 23.09 (down 42.19% YoY), while the FY2025 annual figure was 21.66, down 5.78% from the prior year.
- Interest Coverage Ratio came in at 29.57 for Q1 2026 at Dyadic International, down from 22.78 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2.28 in Q3 2024 to a low of 98.23 in Q1 2024.
- Average Interest Coverage Ratio over 3 years is 28.58, with a median of 22.44 recorded in 2025.
- The largest YoY upside for Interest Coverage Ratio was 77.16% in 2025 against a maximum downside of 882.32% in 2025.
- Over 3 years, Interest Coverage Ratio stood at 17.18 in 2024, then tumbled by 32.56% to 22.78 in 2025, then retreated by 29.81% to 29.57 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 29.57 in Q1 2026, 22.78 in Q4 2025, and 22.41 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | - |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - | -29.57 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -29.57 |
| Dec 31, 2025 | -22.78 |
| Sep 30, 2025 | -22.41 |
| Jun 30, 2025 | -19.33 |
| Mar 31, 2025 | -22.44 |
| Dec 31, 2024 | -17.18 |
| Sep 30, 2024 | -2.28 |
| Jun 30, 2024 | -23.05 |
| Mar 31, 2024 | -98.23 |